Solid Biosciences Inc. Revenue 2016–2022
Solid Biosciences Inc. annual/quarterly revenue history and growth rate from 2016 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Solid Biosciences Inc. revenue for the quarter ending September 30, 2020 was 0.
- Solid Biosciences Inc. revenue for the twelve months ending September 30, 2020 was 0.
- Solid Biosciences Inc. annual revenue for 2022 was 8.1 M, a 40.57% decrease from 2021.
- Solid Biosciences Inc. annual revenue for 2021 was 13.6 M.
- Solid Biosciences Inc. annual revenue for 2020 was 0.
- Solid Biosciences Inc. annual revenue for 2019 was 0.
Solid Biosciences Inc. (SLDB) — Frequently Asked Questions
Solid Biosciences Inc. (SLDB) is a publicly traded US company. It has a market capitalization of $56M. In fiscal 2022 it reported revenue of $8M. Explore SLDB's stock price, financial statements, earnings history, margins and key ratios below.
What is Solid Biosciences Inc.'s market cap?
Solid Biosciences Inc. (SLDB) has a market capitalization of $56M.
What is the SLDB stock price?
SLDB trades at $6.61 (+0.61% on the day).
How much revenue does Solid Biosciences Inc. make?
Solid Biosciences Inc. reported revenue of $8M in fiscal 2022.